Effects of valsartan on expression of inflammatory mediators in mouse glomerular mesangial cells under high concentration glucose

Clinical Focus ›› 2012, Vol. 27 ›› Issue (16): 1414-1.41715e+007.

Previous Articles Next Articles

Effects of valsartan on expression of inflammatory mediators in mouse glomerular mesangial cells under high concentration glucose

LIU Jie;LIU Li;HOU Ming-hui;MENG Jie;LI Hong-yan;MA Yong-jun;YANG Hui

Online:2012-08-20 Published:2012-08-20

Abstract

CLC Number:

R587.24

LIU Jie;LIU Li;HOU Ming-hui;MENG Jie;LI Hong-yan;MA Yong-jun;YANG Hui. Effects of valsartan on expression of inflammatory mediators in mouse glomerular mesangial cells under high concentration glucose[J]. Clinical Focus, 2012, 27(16): 1414-1.41715e+007.

Add to citation manager EndNote|Ris|BibTeX

URL: https://huicui.hebmu.edu.cn/EN/

https://huicui.hebmu.edu.cn/EN/Y2012/V27/I16/1414

[1]	. [J]. Clinical Focus, 2023, 38(6): 564-568.
[2]	Li Huifang, Miao Xia. Prediction of thyroid hormone level on risk of type 2 diabetes nephropathy [J]. Clinical Focus, 2023, 38(2): 137-142.
[3]	He Feng, Nin Lu, Luo Gao, Yang Ruifei, Li Fanfan, Cheng Xiaoqiong, An Binbin, Li Jingjuan, Liu Yuanyuan, Guo Qian, Wang Jinyang. Correlation of Chinese visceral adipose index and visceral fat area with diabetic nephropathy and their warning values [J]. Clinical Focus, 2022, 37(12): 1089-1093.
[4]	Yao Yao, Chu Min. Relationship between serum amyloid β-protein and cognitive dysfunction in patients with diabetic kidney disease [J]. Clinical Focus, 2022, 37(9): 813-816.
[5]	. [J]. Clinical Focus, 2022, 37(5): 467-471.
[6]	Gao Shixin, Song Bing, Shi Kexin. Diagnosis value of serum lipoprotein α, cystatin-C and uric acid on early diabetic nephropathy [J]. Clinical Focus, 2022, 37(3): 248-252.
[7]	. [J]. Clinical Focus, 2022, 37(2): 178-181.
[8]	Liu Lunzhi, Deng Lu, Zhang Mingxia. Effects of angiotensin Ⅱ type 1 receptor blockers on urinary nephrin and Beclin-1 mRNA excretion in urine of patients with early diabetic nephropathy [J]. Clinical Focus, 2021, 36(11): 1005-1008.
[9]	. [J]. Clinical Focus, 2021, 36(11): 1029-1033.
[10]	. [J]. Clinical Focus, 2021, 36(11): 1034-1040.
[11]	Liu Meng, Hu Guicai, Yang Zongna, Guo Weiwei, Chen Wanxin. Comparative study on volume load and nutritional status in hemodialysis patients with diabetic kidney disease and non-diabetic kidney disease [J]. Clinical Focus, 2021, 36(4): 332-335.
[12]	Wang Chunhua. Effect of alprostadil combined with Sanqi Panax Notoginseng Injection on proteinuria in early diabetic nephropathy [J]. Clinical Focus, 2015, 30(12): 1410-1412.
[13]	. [J]. Clinical Focus, 2015, 30(6): 715-717718.
[14]	ZHANG Chang-qin;LUO Yang. Curative effect of torasemide on diabetic nephrotic edema [J]. Clinical Focus, 2014, 29(9): 1002-1004.
[15]	ZHOU Bin;ZHOU Ying-li;FU Yu;SHI Peng;LIN Wei-min;CAO Jia-yue. Effect of alprostadil combined with Shenmai or astragalus in treatment of diabetic nephropathy [J]. Clinical Focus, 2014, 29(7): 724-727.

Effects of valsartan on expression of inflammatory mediators in mouse glomerular mesangial cells under high concentration glucose

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments